Walleye Trading LLC Karuna Therapeutics, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $407,033 - $803,524	2,528 New	2,528 $800,000
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $759,702 - $962,331	-4,709 Reduced 71.66%	1,862 $338,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $615,385 - $760,902	3,213 Added 95.68%	6,571 $1.29 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $478,448 - $1.07 Million	-3,865 Reduced 53.51%	3,358 $755,000
Q2 2022 Aug 08, 2022	BUY	$93.97 - $143.33 $504,055 - $768,822	5,364 Added 288.54%	7,223 $914,000
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $183,855 - $246,075	1,859 New	1,859 $236,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.